Results of the Southwest Oncology Group phase II evaluation (study S0031) of ZD1839 for advanced transitional cell carcinoma of the urothelium.

Source:http://linkedlifedata.com/resource/pubmed/id/19888985

Download in:

View as

General Info

PMID
19888985